2021
DOI: 10.1016/j.poly.2021.115060
|View full text |Cite
|
Sign up to set email alerts
|

PEPPSI type Pd(II)NHC complexes bearing chloro-/fluorobenzyl group: Synthesis, characterization, crystal structures, α-glycosidase and acetylcholinesterase inhibitory properties

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
21
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 35 publications
(22 citation statements)
references
References 69 publications
1
21
0
Order By: Relevance
“…These changes in substrate specificity and transglycosylation activity result from structural changes in the catalytic and substrate binding sites of enzymes. [ 43–45 ]…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…These changes in substrate specificity and transglycosylation activity result from structural changes in the catalytic and substrate binding sites of enzymes. [ 43–45 ]…”
Section: Introductionmentioning
confidence: 99%
“…These changes in substrate specificity and transglycosylation activity result from structural changes in the catalytic and substrate binding sites of enzymes. [43][44][45] Alzheimer's disease (AD) is a progressive degenerative disease that first begins with memory loss and eventually affects all cognition and behavior with a prevalence of over 40 million people worldwide is one of the most common age-related diseases. [46][47][48] This disease is characterized by progressive memory loss, various cognitive impairments, and a decline in language skills.…”
Section: Introductionmentioning
confidence: 99%
“…[3] Hence, inhibition of these enzymes will ultimately reduce this elevated blood-sugar level. [4] Several drug molecules such as Acarbose, Voglibose, some novel molecules [5] and natural products [6] are found to be useful in the treatment of hyperglycemia caused during diabetes. The adverse effects entailing to these drugs have led to further research in identification of potent lead molecules to inhibit the metabolism of dietary sugars via α-glucosidase and α-amylase.…”
Section: Introductionmentioning
confidence: 99%
“…With all this, it is well established that polyphenols also have anti-AD properties and α-glycosidase inhibition profiles. Therefore, one of the most important therapy approaches for neurodegenerative diseases and DM is natural compounds and products including phenolic compounds [28,29,30,31]. However, current evidence demonstrates that patients with DM have an increased risk of developing AD.…”
Section: Introductionmentioning
confidence: 99%